ADDEX THERAPEUTICS LTD (ADXN:NASDAQ)
$3.09 0.16 (5.4608%)
Analysed ADDEX THERAPEUTICS LTD (ADXN:NASDAQ) News Sources
Addex Shareholders Approve All Resolutions at Annual General Meeting
30-06-2026
yahoo.com
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
08-07-2026
yahoo.com
ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027
26-08-2026
yahoo.com
Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
24-09-2026
yahoo.com
Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior
25-09-2026
yahoo.com
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update
28-09-2026
yahoo.com
Addex (ADXN) Q2 2026 Earnings Call Transcript
29-09-2026
fool.com
Addex Therapeutics Announces Executive Management Changes
02-10-2026
yahoo.com
Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia
08-10-2026
yahoo.com
ADDEX INCREASES ISSUED SHARE CAPITAL TO CREATE TREASURY SHARES
29-10-2026
yahoo.com
What is the current price of ADDEX THERAPEUTICS LTD (ADXN:NASDAQ)?
The current price of ADDEX THERAPEUTICS LTD (ADXN:NASDAQ) is $3.09.
ADDEX THERAPEUTICS LTD (ADXN:NASDAQ) absolute price change since previous trading day?
The absolute price change of ADDEX THERAPEUTICS LTD (ADXN:NASDAQ) since the previous trading day is $0.16.
ADDEX THERAPEUTICS LTD (ADXN:NASDAQ) percentage price change since previous trading day?
The percentage price change of ADDEX THERAPEUTICS LTD (ADXN:NASDAQ) since the previous trading day is 5.4608%.
What is the most recent average sentiment score for ADDEX THERAPEUTICS LTD (ADXN:NASDAQ)?
The most recent average sentiment score for ADDEX THERAPEUTICS LTD (ADXN:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for ADDEX THERAPEUTICS LTD (ADXN:NASDAQ)?
The most recent sentiment for ADDEX THERAPEUTICS LTD (ADXN:NASDAQ) is .
SEC-8K** Filing Available For ADDEX THERAPEUTICS LTD (ADXN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.